Subjects and methods: A retrospective and prospective descriptive study on 53 stage IV NSCLC patients who received platinum-based chemotherapy regimens at the Oncology Center - Military Hospital 103 and the Oncology Department - National Lung Hospital from January 2019 to August 2022.